Compound	No.	Name: Synonyms
[11C]ABP688	82	3-(6-methyl-pyridin-2-ylethynyl)-cyclohex-2-enone-O-[11C]methyl-oxime
[11C]ADX88178	94	5-methyl-N-(4-[11C]methylpyrimidin-2-yl)-4-(1H-pyrazol-4-yl) thiazol-2-amine
[11C]AMPA-1905	60	4-cyclopropyl-7-(3-[11C]methoxyphenoxy)-3,4-dihydro-2H-benzo[e][1,2,4] thiadiazine 1,1-dioxide
BIII 277 CL		(−)-(1R,5S,2″R)-3′-Hydroxy-N-(2″-methoxypropyl)-5,9,9-trimethyl-6,7-benzomorphan
Bmax		maximal binding capacity
Boc		t-Boc, tert-butoxycarbonyl group
BPND		binding potential relative to the no displaceable compartment
Bq		Becquerel
cAMP		cyclic adenosine monophosphate
[11C]CBA	45	N-(2-[11C]methoxybenzyl) cinnamamidine
[11C]CMD	89	1-(cyclopropylmethyl)-4-(4-[11C]methoxyphenyl)-piperidin-1-yl-2-oxo- 1,2-dihydropyridine-3-carbonitrile
[*I]CNS1261	37	N-(1-napthyl)-N′-(3-[*I]-iodophenyl)-N-methylguanidine ([*I]CNS-1261
[11C]CNS-5161	36	N-(2-chloro-5-methylthiophenyl)-N′-(3-methylthio-phenyl)-N′-[11C]methylguanidine
Dextrometorphan	19	(+)-3-methoxy-N-methyl-morphinan, (9S,13S,14S)-dextrometorphan, CAS RN: [125-71-3]
Dextrorphan	20	(+)-3-hydroxy-N-methyl-morphinan, (9S,13S,14S)-dextrorphan, CAS RN: [125-73-5]
EEAs		excitatory amino acids
[18F]EFQ	65	3-ethyl-2-[18F]fluoroquinolin- 6-yl-(4-methoxycyclohexyl)methanone
[18F]FE-PE2I	72	(E)-N-(3-iodoprop-2-enyl)-2β-carbo-[18F]fluoroethoxy-3β-(p-tolyl)-nortropane
[18F]FDG		2-deoxy-2-[18F]fluoro-D-glucose, CAS RN: [86783-82-6]
[18F]FITM	69	4-[18F]fluoro-N-[4-[6-(isopropylamino)pyrimidin-4-yl]-1,3-thiazol-2-yl]- N-methylbenzamide
[18F]FMEM	32	1-amino-3-[18F]fluoromethyl-5-methyl-adamantane, [18F]-memantine,
[18F]FNM	33	[18F]fluoroethylnormemantine
EOS		end of synthesis
[18F]FPEB	86	3-[18F]fluoro-5-[(pyridin-3-yl)ethynyl]benzonitrile
[18F]FPEP	87	2-[18F]fluoro-6-[(3-fluorophenyl)ethynyl]pyridine
[18F]FPIT	71	1-(2-[18F] fluoro-3-pyridyl)-4-(2-isopropyl-1-oxo-isoindoline-5-yl)- 5-methyl- 1H-1,2,3-triazole
[18F]FPTQ	73	6-[1-(2-[18F]fluoro-3-pyridyl)-5-methyl-1H-1,2,3-triazol-4-yl]quinolone
[11C]GMOM	34	N-(2-chloro-5-thiomethylphenyl)-N′-(3-[11C]methoxy-phenyl)-N′-methylguanidine
GYKI-52466	54	1-(4-aminophenyl)-4-methyl-7,8-methylenedioxy-5H-2,3-benzodiazepine, CAS RN: [192065-56-8, as hydrochloride]
GYKI-53773	55	(R)-(−)-1-(4-aminophenyl)-3-acetyl-4-methyl-7,8-methylenedioxy-3,4,dihydro-5H- benzodiazepine, talampanel, LY-300164, CAS RN: [161832-65-1]
GYKI-53784	56	(R)-(−)-1-(4-aminophenyl)-3-methylcarbamoyl-4-methyl-7,8-methylenedioxy- 3,4,dihydro-5H-benzodiazepine, LY-303070, CAS RN: [161832-71-9]
[11C]HACH242	49	N-((5-(4-fluoro-2-[11C]methoxyphenyl)pyridin-3-yl)methyl)cyclopentanamine
IC50		inhibition constant required for displacement of 50% of radioligand
ID		injected dose
iGluR		ionotropic glutamate receptors
[11C]ITDM	70	N-[4-[6-(isopropylamino)-pyrimidin-4-yl]-1,3-thiazol-2-yl]-N-methyl- 4-[11C]-methylbenzamide
[11C]ITMM	68	N-[4-[6-(isopropylamino)pyrimidin-4-yl]-1,3-thiazol-2-yl]-4-[11C]methoxy- N-methyl-benzamide
[11C]JNJ16259685	61	(3-ethyl-2-[11C]methyl-6-quinolinyl)(cis- 4-methoxycyclohexyl)methanone
KD		dissociation constant or half-saturation concentration
Ki		inhibition constant in vitro
[11C]L-703717	51	7-chloro-4-hydroxy-3-[3-(4-[11C]methoxybenzyl)phenyl-2-(1H)-quinolone
L-AP4		L-2-amino-4-phosphonobutyrate
Levorphan	18	levorphanol, (−)-3-hydroxy-N-methyl-morphinan, (9R,13R,14R)-levorphan, CAS RN: [77-07-6]
MDD		major depressive disorder
mGluR		metabotropic glutamate receptor
[11C]methyl-BIII 277 CL	39	(−)-(1R,5S,2″R)-3′-[11C]methoxy-N-(2″-methoxypropyl)-5,9,9-trimethyl-6,7-benzomorphan; [2R-[2α,3(R), 6α]-1,2,3,4,5,6-hexahydro-3-(2-methoxypropyl)-6,11,11-trimethyl-2,6-methano-9-[11C]methoxy-3-benzazocine
[11C]M-FPEP	77	2-[11C]methyl-6-(3′-fluoro-phenylethynyl)-pyridine
[11C]Me-NB1	42a	7-[11C]methoxy-3-(4-phenylbutyl)-2,3,4,5-tetrahydro-1H-3-benzazepine-1-ol
[18F]MK-1312	64	1-(2-[18F]fluoro-3-pyridyl)-4-(2-propyl-1-oxo-isoindoline-5-yl)-5-methyl-1H-1,2,3-triazole
[11C]M-MPEP	79	2-(2-(3-[11C]methoxyphenyl)ethynyl)pyridine
[11C]MMTP	63	dimethylamino-3(4-[11C]methoxyphenyl)-3H-pyrido[3′,2′:4,5]thieno- [3,2-d]pyrimidin-4-one
[11C]MPEP	78	2-[11C]methyl-6-(2-phenylethynyl)pyridine
[11C]3MPICA	50	3-[2-[(3-[11C]methoxyphenylamino)carbonyl]ethenyl]-4,6-dichloroindole-2-carboxylic acid
NAAG		N-acetylaspartylglutamic acid, CAS RN: [3106-85-2]
[18F]N2B-0518	48	2-((1-(4-[18F]fluoro-3-methylphenyl)-1H-1,2,3-triazol-4-yl)methoxy)-5-methoxypyrimidine
NB1		3-(4-phenylbutyl)-2,3,4,5-tetrahydro-1H-3-benzazepine-1,7-diol
[11C]NBA	46	N-(2-[11C]methoxybenzyl)-2-naphthamidine
NMDA		N-methyl-D-aspartic acid, CAS RN: [6384-92-5]
NMDAR		N-methyl-D-aspartate receptor
[11C]N2B-1810	52	2-(6-(5-chloro-4-methylthiophen-2-yl)-1H-pyrrolo[3,2-b]pyridin-1-yl)-N-(λ1-methyl-11C)-N-methyl-acetamide
[11C]NR2B-SMe	44	[S-methyl-11C](±)-7-methoxy-3-(4-(4-(methylthio)phenyl)butyl)-2,3,4,5-tetrahydro-1H-benzo[d]azepin-1-ol
[18F]OF-NB1	42b	3-(4-(2-[18F]fluoro-phenyl)butyl)-2,3,4,5-tetrahydro-1H-3-benzazepine-1,7-diol
[18F]PF-NB1	42c	3-(4-(4-[18F]phenyl)butyl)-2,3,4,5-tetrahydro-1H-3-benzazepine-1,7-diol
PCP	23	phencyclidine, CAS RN: [77-10-1]
[18F]FPDEGPECO	88	(E)-3-(pyridin-2-ylethynyl)cyclohex-2-enone O-2-(2-[18]F-fluoroethoxy)ethyl oxime
PET		positron emission tomography
[18F]PK-209	35	([3-(2-chloro-5-(methylthio)phenyl)-1-(3-([18F]fluoromethoxy)phenyl)- 1-methylguanidine]
[18F]PSS232	83	(E)-3-(pyridine-2-yl-etheynyl-1)-cyclohex-2-enon-O-(3-(2-[18F]-fluoroethoxy)propyl) oxime
PTSD		post-traumatic stress disorder
[11C]PTX012253	93	N-(4-chloro-3-([11C]methylthio)phenyl)picolinamide, [11C]KALB012
[11C]QBA	47	N-(2-[11C]methoxybenzyl)quinoline-3-carboxamidine
[11C]QCA	91	7-((2,5-dioxopyrrolidin-1-yl)methyl)-4-(2-fluoro- 4-[11C]methoxyphenyl) quinoline-2-carboxamide
[11C]Ro 04-5595	43	1-(2-(4-chlorophenyl)ethyl)-7-hydroxy-6-methoxy-2-[11C]methyl-1,2,3,4-tetrahydro- isoquinoline
SCAAs		sulfur-containing amino acids
SKF10,047		N-allyl-normetazocine; 2′-hydroxy-5,9-dimethyl-N2-allyl-6,7-benzomorphan; CAS: [825594-24-9]
SPECT		single photon emission computed tomography
SUV		standard uptake value
TBAOH		tetrabutylammonium hydroxide, CAS RN: [2052-49-5]
TCP		N-(1-[thienyl]cyclohexyl)3,4-piperidine, tenocyclidine, CAS RN: [2150098-1]
Versidyne		1-(2-(4-chlorophenyl)ethyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydro-isoquinoline, methopholin, NIH-7672, CAS RN: [2154-02-1]
VT		total distribution volume
[11C]YM-202074	62	N-cyclohexyl-6-{[N-(2-methoxyethyl)-N-[11C]methylamino]methyl}-N-methyl- thiazolo[3,2-a]-benz imidazole-2-carboxamide